ライフサイエンスコーパス: two-dimensional echocardiography

1 thods (quantitative Doppler and quantitative two-dimensional echocardiography).

2 ortic annular calcification were assessed by two-dimensional echocardiography.

3 in asymptomatic children using transthoracic two-dimensional echocardiography.

4 ts underwent 12-lead electrocardiography and two-dimensional echocardiography.

5 al wall motion as determined by quantitative two-dimensional echocardiography.

6 lated shear rates by pulsed wave Doppler and two-dimensional echocardiography.

7 c cirrhosis, have normal cardiac function on two-dimensional echocardiography.

8 rdial infarct size in this canine model than two-dimensional echocardiography.

9 201Tl SPECT, rest 99mTc-sestamibi SPECT and two-dimensional echocardiography.

10 ased systolic tricuspid annulus excursion on two-dimensional echocardiography.

11 tation, compared with prosthesis sizing with two-dimensional echocardiography.

12 y means of history and physical examination, two-dimensional echocardiography, 12-lead and signal-ave

13 art technologies such as PET, SPECT, MRI and two-dimensional echocardiography (2-DE).

14 ) and compares the results with conventional two-dimensional echocardiography (2D).

15 Conventional two-dimensional echocardiography (2DE) has limitations w

16 Two-dimensional echocardiography (2DE) of infants with B

17 Two-dimensional echocardiography (2DE) was applied to pa

18 row computed tomography (MDCT) studies with two-dimensional echocardiography (2DE), and magnetic res

19 energy x-ray absorptiometry [DEXA] scanning, two-dimensional echocardiography [2DE], electrocardiogra

20 icular-functional variables were obtained by two-dimensional echocardiography and Doppler-echocardiog

21 LV function was assessed by LVEF on two-dimensional echocardiography and functional status b

22 ys postreperfusion, function was assessed by two-dimensional echocardiography and PET studies were ob

23 Two-dimensional echocardiography and pulsed Doppler were

24 e testing--stress thallium-201 imaging, rest two-dimensional echocardiography and rest equilibrium ra

25 Using two-dimensional echocardiography and speckle tracking an

26 uated 15 patients with coronary disease with two-dimensional echocardiography and thallium-201 ((201)

27 olic and diastolic function were assessed by two-dimensional echocardiography and tissue Doppler imag

28 ertrophy in affected members was assessed by two-dimensional echocardiography, and patient survival r

29 a steepened aortoseptal angle, as defined by two-dimensional echocardiography, and this association h

30 g sensitivity for abnormal wall motion, with two-dimensional echocardiography as the reference standa

31 -ammonia, 18F-deoxyglucose, and PET and with two-dimensional echocardiography at baseline and during

32 Wall motion and LVEF were assessed by two-dimensional echocardiography before and 158+/-123 da

33 1% males) with flail leaflets diagnosed with two-dimensional echocardiography between 1980 and 1989 w

34 nce of commissural calcification assessed by two-dimensional echocardiography can be used to predict

35 lopment of a qualitatively depressed LVEF on two-dimensional echocardiography, corresponding approxim

36 The left ventricular function as measured by two-dimensional echocardiography decreased in DOX-treate

37 iastolic cross-sectional area (determined by two-dimensional echocardiography) decreased by 53 +/- 16

38 Short-axis two-dimensional echocardiography demonstrated a signific

39 Two-dimensional echocardiography did not reveal systolic

40 These new methods use two-dimensional echocardiography, Doppler echocardiograp

41 signed to compare the accuracy of three- and two-dimensional echocardiography for quantifying the ext

42 Diastolic dysfunction was detected by two-dimensional echocardiography in 5 of 8 and 0 of 8 co

43 excursion and orifice area were measured by two-dimensional echocardiography in 58 patients with glo

44 always be considered when LVEF is normal on two-dimensional echocardiography in patients with clinic

45 Two-dimensional echocardiography is currently the standa

46 Two-dimensional echocardiography is the initial diagnost

47 Two-dimensional echocardiography is the primary diagnost

48 Two-dimensional echocardiography is useful for estimatin

49 e associated with less systolic dysfunction (two-dimensional echocardiography), less diastolic dysfun

50 l wall motion during inflation (quantitative two-dimensional echocardiography) paralleled those of ST

51 :ETHODS AND RESULTS- Two-dimensional echocardiography was performed before se

52 Two-dimensional echocardiography was performed in 190 pa

53 METHODS AND Two-dimensional echocardiography was performed in 427 pa

54 Transthoracic two-dimensional echocardiography was performed in 60 pat

55 Two-dimensional echocardiography was used to assess chan

56 Using two-dimensional echocardiography, we sought to identify

57 entricular cavity dimensions recorded during two-dimensional echocardiography were measured at the le

58 Exercise ECG, ambulatory monitoring, and two-dimensional echocardiography were performed before h

59 In 30 patients with AMI, MCE and two-dimensional echocardiography were performed before P

60 Complete history, physical examination, two-dimensional echocardiography with Doppler and exerci

61 1) thallium imaging with dipyridamole or (2) two-dimensional echocardiography with intravenous dobuta